Early Access — free while we kick the tires
EdgarHawk

LANGER DENNIS

Director

Director
1 filing analyzed · 1 company · Latest 2025-10-15

Companies

Company Buys Sells Direction
Quoin Pharmaceuticals, Ltd. QNRX 1 0 Net buying

Activity

October 2025
high
Buy
15,152 shares
$128,640
Significance 6/10

Director LANGER DENNIS buys 15,152 shares of QNRX at $8.49; holdings surge from 1 to 15,153 shares.

LANGER DENNIS, a director at Quoin Pharmaceuticals, purchased 15,152 shares at $8.49 on 2025-10-14, expanding his position from 1 share to 15,153 shares (+1515200.0% net change). The purchase occurred at a price 44.3% below the current price of $15.27, and coincides with a 30-day price surge of +95.3%, suggesting the director established a meaningful stake well ahead of recent momentum. The transaction signals a material commitment from a board member despite the company's unprofitable state (net income of $-3.7M in the most recent full fiscal year), indicating directional confidence in the company's direction despite current financial headwinds. This substantial position increase by an insider warrants monitoring alongside the company's path to profitability.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access